Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Buono

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 16, 2020
Assessing Insulin and Glucose Tolerance in the Aging MouseRoberta Buono, Sebastian Brandhorst
Trends in Endocrinology and Metabolism: TEM|February 22, 2018
Starvation, Stress Resistance, and CancerRoberta Buono, Valter D Longo
Cell|August 24, 2019
When Fasting Gets Tough, the Tough Immune Cells Get Going-or DieRoberta Buono, Valter D Longo
Frontiers in Oncology|May 1, 2023
Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemiaRoberta Buono, Muneera Alhaddad, David A Fruman
Organic Letters|May 4, 2023
Synthesis of a Complex Brasilicardin Analogue Utilizing a Cobalt-Catalyzed MHAT-Induced Radical Bicyclization ReactionScott W Niman, Roberta Buono, David A Fruman, et al.
Pharmacological Research|May 26, 2011
A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophyClara Sciorati, Daniela Miglietta, Roberta Buono, et al.
Stem Cells (Dayton, Ohio)|November 16, 2011
Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMPRoberta Buono, Chiara Vantaggiato, Viviana Pisa, et al.
Journal of Cell Science|April 3, 2009
Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wastingClara Sciorati, Thierry Touvier, Roberta Buono, et al.
British Journal of Pharmacology|July 2, 2010
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humansClara Sciorati, Roberta Buono, Emanuele Azzoni, et al.
Blood Neoplasia|June 24, 2025
A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategyElizabeth A Brem, Kevin Shieh, Dennis Juarez, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|May 16, 2020
Assessing Insulin and Glucose Tolerance in the Aging MouseRoberta Buono, Sebastian Brandhorst
Trends in Endocrinology and Metabolism: TEM|February 22, 2018
Starvation, Stress Resistance, and CancerRoberta Buono, Valter D Longo
Cell|August 24, 2019
When Fasting Gets Tough, the Tough Immune Cells Get Going-or DieRoberta Buono, Valter D Longo
Frontiers in Oncology|May 1, 2023
Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemiaRoberta Buono, Muneera Alhaddad, David A Fruman
Organic Letters|May 4, 2023
Synthesis of a Complex Brasilicardin Analogue Utilizing a Cobalt-Catalyzed MHAT-Induced Radical Bicyclization ReactionScott W Niman, Roberta Buono, David A Fruman, et al.
Pharmacological Research|May 26, 2011
A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophyClara Sciorati, Daniela Miglietta, Roberta Buono, et al.
Stem Cells (Dayton, Ohio)|November 16, 2011
Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMPRoberta Buono, Chiara Vantaggiato, Viviana Pisa, et al.
Journal of Cell Science|April 3, 2009
Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wastingClara Sciorati, Thierry Touvier, Roberta Buono, et al.
British Journal of Pharmacology|July 2, 2010
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humansClara Sciorati, Roberta Buono, Emanuele Azzoni, et al.
Blood Neoplasia|June 24, 2025
A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategyElizabeth A Brem, Kevin Shieh, Dennis Juarez, et al.
Pageof 3